Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT06141473 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06141473
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2027-05-06
- Enrollment
- 1655
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.